A U.S. District Court recently ruled against Zydus and Lupin, finding Astellas's patent for Myrbetriq was not invalid. Both ...

Zydus MedTech has partnered with Brazil-based Braile Biomedica to commercialize innovative TAVI technology across Europe, ...

The litigation was initiated by Astellas Pharma against Zydus Lifesciences concerning the validity of the ‘780 patent’, which ...

Zydus Lifesciences Ltd (NSE: ZYDUSLIFE) on Friday, April 11, announced that it has received final approval from the United ...

Lupin Ltd. and Zydus Lifesciences Ltd. shares fell sharply after a US court upheld Astellas Pharma's patent on Myrbetriq, ...

Easy Trip Planners Ltd, Dhani Services Ltd, Mahanagar Gas Ltd and Astrazeneca Pharma India Ltd are among the other losers in the BSE's 'A' group today, 16 April 2025.

Sun Pharma declined 0.93 per cent to Rs 1,689.35. About10 per cent of the Sun Pharma's US specialty revenues is formulated in ...

Stocks like NCL Industries, Persistent Systems, Repco Home Finance, JK Cement, Canara Bank, Union Bank of India, and Yatra ...

The GIFT Nifty was indicating a muted start for Indian benchmarks on Tuesday. ICICI Bank Ltd., HCLTech Ltd., and Zydus Lifesciences Ltd. share prices are expected to move because of the news flow over ...